NCT02673060View on ClinicalTrials.gov

A Trial of MBC-11 in Patients With CIBD

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions

Bone Metastasis

Interventions

DRUG

MBC-11

0.5 mg/kg-10 mg/kg , IV (in the vein) on day 1-5 of each 28 day cycle. Number of cycles: 2, in case of partial metabolic reaction or stable metabolic reaction - up to 4.